Subjects with NAFLD, despite high circulating insulin levels, have reduced hepatic insulin sensitivity and postprandial glucose clearance and increased free fatty acid and triglyceride concentrations [7,13,21,44]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.